Kowalyszyn Ruben (@kowalyszynmd) 's Twitter Profile
Kowalyszyn Ruben

@kowalyszynmd

Medico oncologo. Magister en oncologia molecular. Vivo en Viedma. Rio Negro. Patagonia Argentina. Realizo actividad asistencial y en investigacion clinica.

ID: 162726185

calendar_today04-07-2010 14:16:53

3,3K Tweet

787 Followers

633 Following

Asociación Argentina de Oncología Clínica (AAOC) (@aaoncoclinica) 's Twitter Profile Photo

CONGRESO ARG. E INTERNACIONAL AAOC 2025 Reunión institucional AAOC-ESMO Participaron por ESMO, los Dres. Cervantes y André; y por AAOC, los Dres. Claudio Martin, Specterman, Kowalyszyn, Kaen, Bella, Gomez Abuin y Mandó. #CongresoAAOC

CONGRESO ARG. E INTERNACIONAL AAOC 2025
Reunión institucional AAOC-ESMO
Participaron por ESMO, los Dres. Cervantes y André; y por AAOC, los Dres. Claudio Martin, Specterman, Kowalyszyn, Kaen, Bella, Gomez Abuin y Mandó.
#CongresoAAOC
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Biomarker analysis of KN-119 of pembro vs chemo in pretreated mTNBC out in NPJ Breast. Pembro improved OS in pts with TILs ≥5%, no benefit if TILs<5%. Still waiting for the TILs analysis of KN-522, which we hope could refine the use of neoadjuvant pembro. nature.com/articles/s4152…

Biomarker analysis of KN-119 of pembro vs chemo in pretreated mTNBC out in NPJ Breast. Pembro improved OS in pts with TILs ≥5%, no benefit if TILs&lt;5%. Still waiting for the TILs analysis of KN-522, which we hope could refine the use of neoadjuvant pembro. nature.com/articles/s4152…
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Long-term survival from the trial that changed breast oncology, out in Nature Medicine. Confirmed OS benefit for T-DXd over chemo for pretreated HER2-low MBC. As it often happens with ADCs, the OS delta (6 months) exceeds the PFS benefit (4-5 months). nature.com/articles/s4159…

Long-term survival from the trial that changed breast oncology, out in <a href="/NatureMedicine/">Nature Medicine</a>. Confirmed OS benefit for T-DXd over chemo for pretreated HER2-low MBC. As it often happens with ADCs, the OS delta (6 months) exceeds the PFS benefit (4-5 months). nature.com/articles/s4159…
LACOG - Latin American Cooperative Oncology Group (@lacog_group) 's Twitter Profile Photo

LACOG participated in the BIG Scientific Meeting, held in Berlin, a meeting that precedes the ESMO Congress 2025. The meeting brought together oncologists from around the world, including Latin America and members of the LACOG Breast Board. #LACOG #CancerResearch

LACOG participated in the BIG Scientific Meeting, held in Berlin, a meeting that precedes the ESMO Congress 2025. 

The meeting brought together oncologists from around the world, including Latin America and members of the LACOG Breast Board.

#LACOG
#CancerResearch
Asociación Argentina de Oncología Clínica (AAOC) (@aaoncoclinica) 's Twitter Profile Photo

REUNIÓN ESMO-AAOC La Asociación Argentina de Oncología Clínica mantuvo una reunión de fortalecimiento institucional con las autoridades de la European Society for Medical Oncology, durante el Congreso que ESMO organiza este año en la ciudad de Berlin  aaoc.org.ar/reunion-esmo-a…

REUNIÓN ESMO-AAOC
La Asociación Argentina de Oncología Clínica mantuvo una reunión de fortalecimiento institucional con las autoridades de la European Society for Medical Oncology, durante el Congreso que ESMO organiza este año en la ciudad de Berlin 
aaoc.org.ar/reunion-esmo-a…